Published in Lancet Oncol on August 01, 2007
Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol (2009) 2.88
Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics (2009) 1.40
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed (2011) 1.39
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol (2012) 1.16
Children's Oncology Group's 2013 blueprint for research: central nervous system tumors. Pediatr Blood Cancer (2012) 1.14
Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol (2008) 1.12
Three-dimensional conformal radiation therapy for ependymoma. Childs Nerv Syst (2009) 1.00
Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis. Childs Nerv Syst (2009) 0.95
Use of T2 signal intensity of cerebellar neoplasms in pediatric patients to guide preoperative staging of the neuraxis. J Neurosurg Pediatr (2011) 0.95
Survival following treatment for intracranial ependymoma: a review. Childs Nerv Syst (2009) 0.95
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis. PLoS One (2010) 0.94
Ependymoma: lessons from the past, prospects for the future. Childs Nerv Syst (2009) 0.92
Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial. J Neurooncol (2013) 0.88
Functional and neuropsychological late outcomes in posterior fossa tumors in children. Childs Nerv Syst (2015) 0.86
High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma. Neuro Oncol (2011) 0.86
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol (2016) 0.86
A common polymorphism in the 5' UTR of ERCC5 creates an upstream ORF that confers resistance to platinum-based chemotherapy. Genes Dev (2015) 0.86
Posterior fossa ependymoma: current insights. Childs Nerv Syst (2015) 0.84
Comparison of the dosimetries of 3-dimensions Radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma. BMC Med Phys (2012) 0.83
Carboplatin-based primary chemotherapy for infants and young children with CNS tumors. Cancer (2009) 0.81
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix. PLoS One (2013) 0.81
Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Sci Transl Med (2016) 0.81
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain. Neuro Oncol (2017) 0.80
Posterior fossa tumors in infants and neonates. Childs Nerv Syst (2015) 0.80
Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors. Neuro Oncol (2014) 0.80
Paediatric ependymomas: should we avoid radiotherapy? Lancet Oncol (2007) 0.80
Management strategies for recurrent ependymoma in the paediatric population. Childs Nerv Syst (2009) 0.79
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models. Neuro Oncol (2014) 0.77
Spinal cord ependymomas in children and adolescents. Childs Nerv Syst (2012) 0.77
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children. Curr Neurol Neurosci Rep (2009) 0.75
Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric Ependymoma. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34. Neuro Oncol (2013) 0.75
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. Neuro Oncol (2016) 0.75
Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun (2016) 0.75
Primary radiotherapy for childhood ependymoma? Lancet Oncol (2007) 0.75
Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey. Springerplus (2016) 0.75
Surgical considerations in fourth ventricular ependymoma with the transcerebellomedullary fissure approach in focus. Childs Nerv Syst (2009) 0.75
Neuroendoscopic management of posterior third ventricle ependymoma with intraaqueductal and fourth ventricle extension: a case report and review of the literature. Childs Nerv Syst (2017) 0.75
Surgical management of supratentorial ependymomas. Childs Nerv Syst (2009) 0.75
Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation. Childs Nerv Syst (2017) 0.75
Assessing 'second-look' tumour resectability in childhood posterior fossa ependymoma-a centralised review panel and staging tool for future studies. Childs Nerv Syst (2016) 0.75
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet (2012) 7.61
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol (2008) 6.66
Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94
Tracking the clonal origin of lethal prostate cancer. J Clin Invest (2013) 5.79
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature (2008) 5.59
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol (2010) 4.94
Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma. J Clin Oncol (2013) 3.81
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol (2011) 3.56
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
A prion protein epitope selective for the pathologically misfolded conformation. Nat Med (2003) 3.41
The origins of medulloblastoma subtypes. Annu Rev Pathol (2008) 3.36
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol (2009) 3.32
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol (2014) 3.21
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell (2009) 3.11
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell (2011) 2.87
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol (2005) 2.84
Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med (2009) 2.73
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol (2008) 2.72
Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer (2006) 2.39
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis. Cell Cycle (2006) 2.37
A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin Cancer Res (2010) 2.37
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest (2006) 2.27
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet (2008) 2.24
A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell (2012) 2.15
Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol (2010) 2.01
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell (2011) 1.78
Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett (2005) 1.77
Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med (2014) 1.74
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res (2004) 1.67
Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol (2007) 1.67
Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol (2007) 1.59
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. J Clin Oncol (2010) 1.58
Anterior chamber depth and the risk of primary angle closure in 2 East Asian populations. Arch Ophthalmol (2005) 1.58
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res (2002) 1.58
Bayesian two-stage designs for phase II clinical trials. Stat Med (2002) 1.56
Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Dev Med Child Neurol (2010) 1.53
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol (2010) 1.48
Skull base surgery for tumors in children: long-term clinical and functional outcome. J Neurosurg Pediatr (2013) 1.46
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol (2010) 1.46
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop. J Neurosurg Spine (2010) 1.45
Intraventricular and skull base neuroendoscopy in 2012: a global survey of usage patterns and the role of intraoperative neuronavigation. World Neurosurg (2013) 1.45
Safety of audiology direct access for medicare patients complaining of impaired hearing. J Am Acad Audiol (2010) 1.45
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*. Brain Pathol (2008) 1.40
Sample sizes for estimating differences in proportions--can we keep things simple? J Biopharm Stat (2012) 1.39
Congenital perisylvian dysfunction - is it a spectrum? Dev Med Child Neurol (2009) 1.38
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc Natl Acad Sci U S A (2004) 1.37
Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma. Genes Chromosomes Cancer (2006) 1.35
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol (2011) 1.33
Rapid diagnosis of medulloblastoma molecular subgroups. Clin Cancer Res (2011) 1.33
Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One (2009) 1.33
High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology (2002) 1.32
Quality of life in an urban Asian population: the impact of ethnicity and socio-economic status. Soc Sci Med (2003) 1.32
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer (2010) 1.30
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol (2013) 1.27
Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics (2006) 1.27
Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer (2005) 1.27
Determinants of intraocular pressure and its association with glaucomatous optic neuropathy in Chinese Singaporeans: the Tanjong Pagar Study. Invest Ophthalmol Vis Sci (2003) 1.26
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin Cancer Res (2009) 1.24
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study. J Clin Oncol (2010) 1.24
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Survival and long-term health and cognitive outcomes after low-grade glioma. Neuro Oncol (2010) 1.22
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer (2006) 1.22
Dynamic internal gradients control and direct electric currents within nanostructured materials. Nat Nanotechnol (2011) 1.21
Ocular biometry and refraction in Mongolian adults. Invest Ophthalmol Vis Sci (2004) 1.20
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev (2009) 1.20
Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol (2010) 1.20
Initial management of hydrocephalus associated with Chiari malformation Type I-syringomyelia complex via endoscopic third ventriculostomy: an outcome analysis. J Neurosurg (2008) 1.20
Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J (2005) 1.20
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clin Cancer Res (2013) 1.20
Childhood solid tumours: a developmental disorder. Nat Rev Cancer (2005) 1.20
Young age may predict a better outcome for children with diffuse pontine glioma. Cancer (2008) 1.18
Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model. Cancer Res (2011) 1.17
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol (2012) 1.16
Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys (2003) 1.16
Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer (2004) 1.14